Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 4/20 | 0.78 |
| ▸ | MGLL | Q99685 | 3/20 | 0.78 |
| ▸ | CA2 | P00918 | 3/20 | 0.78 |
| ▸ | ENPP2 | Q13822 | 3/20 | 0.54 |
| ▸ | CA4 | P22748 | 1/20 | 0.54 |
| ▸ | CA6 | P23280 | 1/20 | 0.54 |
| ▸ | CA5A | P35218 | 1/20 | 0.54 |
| ▸ | CA7 | P43166 | 1/20 | 0.54 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.54 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.54 |
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2754556 | 1.00 | CA1 (0.78) | CA1MGLLCA2ENPP2CA4 | |
| SCHEMBL29746430 | 1.00 | CA1 (0.78) | CA1MGLLCA2ENPP2CA4 | |
| SCHEMBL19733203 | 0.98 | CA1 (0.75) | CA1MGLLCA2ENPP2CA4 | |
| SCHEMBL4002624 | 0.98 | CA1 (0.75) | CA1MGLLCA2ENPP2CA4 | |
| SCHEMBL20515843 | 0.98 | CA1 (0.75) | CA1MGLLCA2ENPP2CA4 | |
| SCHEMBL19733197 | 0.98 | CA1 (0.75) | CA1MGLLCA2ENPP2CA4 | |
| SCHEMBL12424910 | 0.98 | CA1 (0.75) | CA1MGLLCA2ENPP2CA4 | |
| SCHEMBL19733154 | 0.98 | CA1 (0.75) | CA1MGLLCA2ENPP2CA4 | |
| SCHEMBL19733188 | 0.96 | CA2 (0.71) | CA1MGLLCA2ENPP2CA4 | |
| SCHEMBL17731991 | 0.96 | CA2 (0.71) | CA1MGLLCA2ENPP2CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022050533-A1 | NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME | 주식회사 엘지화학 | 2022-03-10 | — | — | WO | disclosed |
| US-11208368-B2 | Double-spiro type compound and organic light-emitting device containing same | LG CHEM, LTD. (KR) | 2021-12-28 | — | — | US | disclosed |
| CN-109111461-B | Novel compound and application thereof in electroluminescent device | 北京鼎材科技有限公司 | 2021-09-10 | — | — | CN | disclosed |
| US-20190345082-A1 | DOUBLE-SPIRO TYPE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING SAME | LG CHEM, LTD. (KR) | 2019-11-14 | — | — | US | disclosed |
| US-20180002256-A1 | DOUBLE-SPIRO TYPE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING SAME | LG CHEM, LTD. (KR) | 2018-01-04 | — | — | US | disclosed |
| EP-3260438-A1 | DOUBLE-SPIRO TYPE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING SAME | LG Chem, Ltd. (KR) | 2017-12-27 | — | — | EP | disclosed |
| US-9028977-B2 | Compound, method for preparing same and organic electronic device using same | LG CHEM, LTD. (KR) | 2015-05-12 | — | — | US | disclosed |
| US-9028977-B2 | Compound, method for preparing same and organic electronic device using same | LG CHEM, LTD. (KR) | 2015-05-12 | — | — | US | disclosed |
| WO-2012115394-A2 | COMPOUND, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF | 덕산하이메탈(주) (KR) | 2012-08-30 | — | — | WO | disclosed |
| US-20110168992-A1 | NOVEL COMPOUND, METHOD FOR PREPARING SAME AND ORGANIC ELECTRONIC DEVICE USING SAME | LG CHEM, LTD. (KR) | 2011-07-14 | — | — | US | disclosed |
| US-20110168992-A1 | NOVEL COMPOUND, METHOD FOR PREPARING SAME AND ORGANIC ELECTRONIC DEVICE USING SAME | LG CHEM, LTD. (KR) | 2011-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11208368-B2 | Double-spiro type compound and organic light-emitting device containing same | NR2E3, CRY1, CRY2 | CA1 3758/4885MGLL 2770/4885CA2 3290/4885 |
| US-20190345082-A1 | DOUBLE-SPIRO TYPE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING SAME | NR2E3, CRY1, CRY2 | CA1 3758/4885MGLL 2770/4885CA2 3290/4885 |
| US-20180002256-A1 | DOUBLE-SPIRO TYPE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING SAME | NR2E3, CRY1, CRY2 | CA1 3758/4885MGLL 2770/4885CA2 3290/4885 |
| US-20110168992-A1 | NOVEL COMPOUND, METHOD FOR PREPARING SAME AND ORGANIC ELECTRONIC DEVICE USING SAME | OR10J3, USE1, NOTUM | CA1 4266/4885MGLL 2568/4885CA2 3850/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.